Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ken Hamasaki is active.

Publication


Featured researches published by Ken Hamasaki.


Clinical Rheumatology | 2003

Systemic lupus erythematosus and thrombotic thrombocytopenic purpura: a case report and literature review.

Ken Hamasaki; Toshihide Mimura; Hiroko Kanda; Kanae Kubo; K. Setoguchi; T. Satoh; Yoshikata Misaki; Kazuhiko Yamamoto

AbstractWe describe a patient with systemic lupus erythematosus (SLE) who developed severe and acute thrombotic thrombocytopenic purpura (TTP). Detection of the fragmentation of peripheral red blood cells (RBC) helped the early diagnosis of TTP and the patient was rescued by extensive plasma exchange started promptly after the diagnosis. Because manifestations of TTP are similar to those in SLE, it is sometimes difficult to make an accurate diagnosis of TTP in SLE patients. We emphasise here the significance of the early diagnosis of TTP by the observation of fragmented RBC and the intensive therapy, including plasma exchange, for this very severe condition.


Immunology | 1999

Glomerular overexpression and increased tyrosine phosphorylation of focal adhesion kinase p125FAK in lupus-prone MRL/MP-lpr/lpr mice.

Noritsugu Morino; T Matsumoto; Kazue Ueki; Toshihide Mimura; Ken Hamasaki; Hiroko Kanda; T Naruse; Yoshio Yazaki; Yoshihisa Nojima

Much progress has been made in understanding how mammalian cells receive a diverse array of external stimuli and convert them into intracellular biochemical signals. Such efforts have identified a large number of signalling molecules. However, our knowledge is limited as to their pathophysiological role in particular diseases. We demonstrate herein that an integrin‐linked signalling molecule, focal adhesion kinase p125FAK (FAK), is overexpressed in glomeruli of lupus‐prone MRL/MP‐lpr/lpr (MRL‐lpr) mouse as compared to its congeneic MRL‐+/+ strain. Increased expression was specifically demonstrated in glomeruli but not in other tissues examined. The overexpression was observed in 16‐week‐old MRL‐lpr mice with active nephritis, as well as in younger animals at 4 weeks of age. Thus, the upregulation of FAK clearly preceded the clinical onset of nephritis. FAK in MRL‐lpr glomeruli is highly tyrosine phosphorylated and is associated with adapter protein Grb2. Previous in vitro studies have shown that the association of FAK/Grb2 links cell adhesion to the Ras pathway, which ultimately stimulates mitogen‐activated protein (MAP) kinase, an important regulator of cell proliferation. In accordance, we observed constitutive MAP kinase activation in MRL‐lpr glomeruli. Our findings suggest that signalling pathways involving FAK are activated in MRL‐lpr glomeruli, and are likely to play a role in the development and progression of autoimmune‐mediated murine nephritis.


Nephron | 1995

Nephrotic syndrome developed in a patient with acute promyelocytic leukemia treated with daunomycin.

Noritsugu Morino; Yoshihisa Nojima; Toshihide Mimura; Ken Hamasaki; Tetsuya Nakamoto; Hisamaru Hirai; Masami Arai; Shoji Matsuya; Yoshio Yazaki

Noritsugu Morino, MD, The Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113 (Japan) Dear Sir, Nephrotic syndrome (NS) is an unusual but well-recognized complication of malignant diseases [1,2]. Among the hematologi-cal neoplasms, lymphocytic leukemia and lymphoma have a known association with NS, while its occurrence in the acute myelog-enous leukemia (AML) appears to be exceedingly rare [2]. To the best of our knowledge, there have been only two reports in the literature [3, 4]. We report here a case of acute promyelocytic leukemia (APL) associated with NS. The development of NS was coincidental with the administration of chemotherapy in this case. A 32-year-old Japanese woman presented at our hospital with progressive fatigue and gingival bleeding which had developed 2 weeks earlier. Until then she had been in excellent health with no history of renal disease or drug exposure. The physical examination was normal except for anemic conjunctiva and purpuric lesions scattered on the upper chest. The hematocrit was 21.4%, WBC 34.1 × 109/1 with 12% blast cells and 70% promyelocytes, and the platelet count was 22 × 109/1. Coagulation studies demonstrated that the patient had disseminated intravascular coagulation (DIC). Urinalysis showed trace amounts of protein, and the sediment was normal. Serum albumin was 4.5 g/dl, urea nitrogen 16.3 mg/dl, and creat-inine 0.6 mg/dl. The bone marrow aspirate showed increased cellularity with 13.2% myeloblasts and 82.4% promyelocytes. The 1⁄8 · · β ‘ Fig. 1. a Ligh micrograph of a glomerulus showing minor abnormalities. HE. × 200. b Electron micrograph showing widespread detachment of epithelial cells from GBM. × 8,000. Serum albumin was 3.0 g/dl on the 15th hospital day. Thus, the patient developed NS during the course of chemotherapy for APL. Anticoagulant therapy had little effect on her severe DIC, and the patient died on the 16th day because of massive hemorrhage into both lungs.


Scandinavian Journal of Rheumatology | 2000

Impaired collagen gel contraction with cultured skin fibroblasts from patients with systemic sclerosis.

Noritsugu Morino; Toshihide Mimura; Ken Hamasaki; Hiroko Kanda; Kanako Kikuchi; Kazuhiko Takehara; Yoshio Yazaki; Yoshihisa Nojima

We investigated the capacity of skin fibroblasts, derived from 9 patients with systemic sclerosis (SSc), to contract collagen lattices in a three-dimensional culture system. In comparison with control fibroblasts (N = 8), more than 30% of SSc fibroblasts exhibited markedly impaired ability to contract collagen lattices. The expression of alpha2beta1 integrins and integrin-mediated signals were not significantly different between normal and SSc fibroblasts. Although the underlying mechanisms remain to be determined, our present data provide evidence that certain aspects of interaction with collagen are impaired in SSc fibroblasts.We investigated the capacity of skin ®broblasts, derived from 9 patients with systemic sclerosis (SSc), to contract collagen lattices in a threedimensional culture system. In comparison with control ®broblasts (N~8), more than 30% of SSc ®broblasts exhibited markedly impaired ability to contract collagen lattices. The expression of a2b1 integrins and integrin-mediated signals were not signi®cantly different between normal and SSc ®broblasts. Although the underlying mechanisms remain to be determined, our present data provide evidence that certain aspects of interaction with collagen are impaired in SSc ®broblasts.


Journal of Biological Chemistry | 1995

Integrin-mediated Cell Adhesion Promotes Tyrosine Phosphorylation of p130, a Src Homology 3-containing Molecule Having Multiple Src Homology 2-binding Motifs

Yoshihisa Nojima; Noritsugu Morino; Toshihide Mimura; Ken Hamasaki; Hiroko Furuya; Ryuichi Sakai; Toshiya Sato; Kouichi Tachibana; Chikao Morimoto; Yoshio Yazaki; Hisamaru Hirai


Journal of Biological Chemistry | 1995

MATRIX/INTEGRIN INTERACTION ACTIVATES THE MITOGEN-ACTIVATED PROTEIN KINASE, P44ERK-1 AND P42ERK-2

Noritsugu Morino; Toshihide Mimura; Ken Hamasaki; Kazuyuki Tobe; Kohjiro Ueki; Kanako Kikuchi; Kazuhiko Takehara; Takashi Kadowaki; Yoshio Yazaki; Yoshihisa Nojima


Biochemical and Biophysical Research Communications | 1996

Src Kinase Plays an Essential Role in Integrin-Mediated Tyrosine Phosphorylation of Crk-Associated Substrate p130Cas

Ken Hamasaki; Toshihide Mimura; Noritsugu Morino; Hiroko Furuya; Tetsuya Nakamoto; Shinichi Aizawa; Chikao Morimoto; Yoshio Yazaki; Hisamaru Hirai; Yoshihisa Nojima


Kidney International | 2001

Influence of various hemodialysis membranes on the plasma (1→3)-β-D-glucan level

Hiroko Kanda; Kanae Kubo; Ken Hamasaki; Yoshinobu Kanda; Akihide Nakao; Tadaichi Kitamura; Toshiro Fujita; Kazuhiko Yamamoto; Toshihide Mimura


Biochemical and Biophysical Research Communications | 1995

Stretching Mesangial Cells Stimulates Tyrosine Phosphorylation of Focal Adhesion Kinase pp125FAK

Ken Hamasaki; Toshihide Mimura; Hiroko Furuya; Noritsugu Morino; T. Yamazaki; I. Komuro; Yoshio Yazaki; Yoshihisa Nojima


The Journal of Rheumatology | 2002

Antiinflammatory effect of simvastatin in patients with rheumatoid arthritis.

Hiroko Kanda; Ken Hamasaki; Kanae Kubo; Shoko Tateishi; Aki Yonezumi; Yoshinobu Kanda; Kazuhiko Yamamoto; Toshihide Mimura

Collaboration


Dive into the Ken Hamasaki's collaboration.

Top Co-Authors

Avatar

Toshihide Mimura

Saitama Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge